
09/08/2025
🧪 A new study compares two thiazides—chlorthalidone (CTD) and hydrochlorothiazide (HCTZ)—for kidney stone prevention. CTD showed a stronger and more consistent reduction in urine calcium, especially with morning dosing, while HCTZ had minimal effect. These findings support CTD as the preferred option for reducing stone risk.
Click to read the full article: https://bit.ly/4mmFw2l